Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

PNU157706 reduced rat sperm movement and fertility without affecting offspring health.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

Entadfi, a mix of finasteride and tadalafil, is used for BPH.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

The RISUG-PH™ implant effectively delivers finasteride to the prostate through the vas deferens.

Combination therapy is more effective for prostate volumes over 60 ml.

PM-9 and finasteride effectively inhibit the enzyme that converts testosterone to DHT.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction, but the exact reasons are unclear.

SPET-085 effectively inhibits an enzyme linked to prostate issues, similar to finasteride.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Post-Finasteride Syndrome causes lasting sexual, mood, and metabolic issues, needing personalized treatment and better informed consent.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Dutasteride effectively treats enlarged prostate with manageable side effects.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Finasteride reduces movement issues in Parkinson's disease rats.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

5ARIs effectively treat and manage BPH by reducing prostate size and symptoms.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

Men using 5-alpha reductase inhibitors for prostate issues may have a slightly higher risk of blood clots.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.